Rhone Ma Holdings Bhd banner

Intrinsic Value

The intrinsic value of Rhone Ma Holdings Bhd (RHONEMA) under the Base Case is 0.88 MYR per share. Compared with the current market price of 0.69 MYR, the stock appears Undervalued by 22% .

The intrinsic value is the average of valuations using the DCF method and multiples.

Do our valuations actually work? See backtest results .

RHONEMA Intrinsic Value
0.88 MYR
Undervaluation 22%
Intrinsic Value
Price 0.69 MYR
R

RHONEMA is cheaper than usual. It was this cheap or cheaper on just 12% of days in the past 5 years.

Monitor RHONEMA
Get notified when the price drops
Track Buy Zone
20% below Intrinsic Value 0.71
Get notified when the price drops into your buy zone
Intrinsic Value 0.88
Margin of Safety 20% 0.71
Current Price 0.69
Or choose another margin of safety
0% below Intrinsic Value
10% below Intrinsic Value
30% below Intrinsic Value
40% below Intrinsic Value
50% below Intrinsic Value
Custom
Alternatives to RHONEMA

Fundamental Analysis

What Rhone Ma Holdings Bhd Does

Pharmaceuticals Health Care

Rhone Ma Holdings Bhd is a Malaysian company that sells animal health and nutrition products, mainly for livestock and poultry. It supplies veterinary medicines, feed additives, disinfectants, and related products that help farmers prevent disease and improve animal productivity. The company also provides technical support and advice to customers on how to use these products effectively.

Headquarters
Malaysia MY
IPO date
Dec 19, 2016
Read the full company overview
View Company Overview
Financials
Efficiency

Earnings Waterfall
Rhone Ma Holdings Bhd

Wall St Price Targets

Capital Returns

Competitive Landscape

What is the Intrinsic Value of one RHONEMA stock?

The intrinsic value for Rhone Ma Holdings Bhd (RHONEMA) under the Base Case is 0.88 MYR.

Is RHONEMA stock undervalued or overvalued?

Compared with the current market price of 0.69 MYR, the stock appears Undervalued by 22% .

Back to Top